Based on the Golden Meditech Holdings Limited stock forecasts from 0 analysts, the average analyst target price for Golden Meditech Holdings Limited is not available over the next 12 months. Golden Meditech Holdings Limited’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Golden Meditech Holdings Limited is Very Bearish, which is based on 0 positive signals and 2 negative signals. At the last closing, Golden Meditech Holdings Limited’s stock price was HKD 18.82. Golden Meditech Holdings Limited’s stock price has changed by +0.00% over the past week, +0.00% over the past month and +0.00% over the last year.
No recent analyst target price found for Golden Meditech Holdings Limited
No recent average analyst rating found for Golden Meditech Holdings Limited
Company Overview
Golden Meditech Holdings Limited, an investment holding company, operates as an integrated healthcare company in the People's Republic of China. It operates in five segments: Medical Devices, Hospital Business, Medical Insurance Administration, Chinese Herbal Medicines, and Cells and Tissues Storage and Genetic Testing Services. The Medical Devices segment develops, manufactures, and sells medical devices and accessories that are specialized in blood recovery, purification, and treatment. The Hospital Business segment offers hospital management services; and operates three hospitals in Beijing and Shanghai that provide obstetrics, gynecology, and pediatric medical services, as well as haematology treatments and other healthcare services. The Medical Insurance Administration segment offers medical insurance administration services. This segment provides operational and information technology solutions to insurance companies and healthcare institutions, as well as offers bill settlement, and review management and services to governmental healthcare insurance agencies. The Chinese Herbal Medicine segment engages in the research and development, manufacture, and sale of Chinese herbal medicines. The Cells and Tissues Storage and Genetic Testing Services segment engages in the collection, processing, storage, and clinical application of cells and tissues, as well as provision of clinical molecular genetic testing and molecular pathology testing services. The company also engages in the software design business. Golden Meditech Holdings Limited has a collaboration with the Department of Biology of Hong Kong Baptist University to conduct research in the area of cell therapy. The company was formerly known as Golden Meditech Company Limited and changed its name to Golden Meditech Holdings Limited in March 2010. Golden Meditech Holdings Limited was incorporated in 2001 and is headquartered in Beijing, the People's Republic of China. Read Less
Golden Meditech Holdings Limited, an investment holding company, operates as an integrated healthcare company in the People's Republic of China. It operates in five segments: Medical Devices, Hospital Business, Medical Insurance Administration, Chinese Herbal Medicines, and Cells...Read More
Stock Target Advisor's fundamental analysis for Golden Meditech Holdings Limited's stock is Very Bearish.
Unfortunately we do not have enough data on 0801:HK's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on 0801:HK's stock to indicate what its average analyst target is.
0801:HK stock's Price/Earning ratio is -99,999.99.
Based on this 0801:HK may be a overvalued for its sector.
The last closing price of 0801:HK's stock was HKD 18.82.
The most recent market capitalization for 0801:HK is HKD 2.54B.
Unfortunately we do not have enough analyst data on 0801:HK's stock to indicate whether its price will go up or not.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
There is nothing we particularly like
What not to like
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative earnings
The company had negative total earnings in the most recent four quarters.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for 0801:HK !
Please login to proceed
Sorry - extended search is only available for registered users.
